How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Gordon Scott has been an active investor and technical analyst for 20+ years. He is a Chartered Market Technician (CMT). LumiNola / Getty Images The treasury stock method is a technique used by ...

Air Methods Corp. provides air medical transportation services throughout the United States and design, manufacture, and install medical aircraft interiors and other aerospace and medical transport ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Computational models are mathematical models used to numerically study the behaviour of complex systems by means of a computer simulation. A computational model can be used to make predictions of the ...

We developed an optogenetic tool based on tetanus neurotoxin — a protease that cleaves the synaptic vesicle fusion protein VAMP2 to inhibit neurotransmitter release. We show that this light-controlled ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...